ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans.

Tianzhou Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.